RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MOLINARI M
Collezione AOU Novara

Items : 2

High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.

2023
AOU Alessandria
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Foà R; Nanni M; Del Giudice I; Guarini A; Fazi P; Vignetti M; Piciocchi A; Cuneo A; Neri A; De Novi LA; De Propris MS; Pietrasanta D; Mattiello V; Visentin A; Vitale C; Albano F; Molinari MC; Liberati AM; Giordano A; Gottardi D; Galieni P; Patrizi VB; Tani M; Arcari A; Musuraca G; Deodato M; Massaia M; Rigolin GM; Scarfò L; et alii...

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)(1). in Autophagy

2021
AOU Novara

Klionsky DJ; Abdel-Aziz AK; Abdelfatah S; Abdellatif M; Abdoli A; Abel S; Abeliovich H; Abildgaard MH; Abudu YP; Acevedo-Arozena A; Adamopoulos IE; Adeli K; Adolph TE; Adornetto A; Aflaki E; Agam G; Agarwal A; Aggarwal BB; Agnello M; Agostinis P; Agrewala JN; Agrotis A; Aguilar PV; Ahmad ST; Ahmed ZM; Ahumada-Castro U; Aits S; Aizawa S; Akkoc Y; et alii...